Human Mycobacterium bovis infection in Buenos Aires: epidemiology, microbiology and clinical presentation

Int J Tuberc Lung Dis. 2012;16(3):415-7. doi: 10.5588/ijtld.10.0605. Epub 2012 Jan 5.

Abstract

We performed a retrospective study of clinical, epidemiological and microbiological characteristics of patients with confirmed Mycobacterium bovis infection treated at Francisco Muñiz Hospital, Buenos Aires, Argentina, between 1996 and 2008. A total of 39 patients were included, accounting for 0.4% of tuberculosis cases in our hospital. Of these, 93% had at least one risk factor for M. bovis; the most frequent was occupational exposure (65%), followed by history of living in a rural area (31%) and consumption of unpasteurised milk (4%). Pulmonary disease was the most frequent clinical presentation. Rifampicin resistance and multidrug resistance were seen in two patients, both of whom had human immunodeficiency virus infection.

MeSH terms

  • Adult
  • Animals
  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / therapeutic use*
  • Argentina / epidemiology
  • Female
  • HIV Infections / complications
  • Humans
  • Male
  • Middle Aged
  • Milk / microbiology
  • Mycobacterium bovis / isolation & purification*
  • Occupational Diseases / drug therapy
  • Occupational Diseases / epidemiology
  • Occupational Diseases / microbiology
  • Retrospective Studies
  • Rifampin / therapeutic use
  • Risk Factors
  • Rural Population
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology*
  • Tuberculosis / microbiology
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Tuberculosis, Multidrug-Resistant / microbiology

Substances

  • Antitubercular Agents
  • Rifampin